查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587505

聚合物生物分析測試服務市場規模、佔有率、趨勢分析報告：2025-2030 年按階段、測試、類型、治療領域、最終用途、地區和細分市場預測

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test (ADME, PD), By Type, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

聚合物生物分析測試服務市場的成長與趨勢

Grand View Research, Inc.最新報告顯示，預計到2030年，全球聚合物生物分析測試服務市場規模將達37億美元，2025年至2030年複合年成長率為9.63%。

在生物標記、大分子和其他物質的臨床測試中擴大使用生物分析測試是該行業的主要驅動力。新興國家慢性病盛行率的上升和臨床檢測需求的增加是推動市場成長的因素。例如，根據世界衛生組織的數據，2020 年約有 1,000 萬人將死於癌症。根據癌症估計，到 2040 年，可能有 3,020 萬人受到癌症的影響。預計推動該細分市場成長的其他因素包括生技藥品數量的增加、對先進技術的高需求以及對個人化孤兒藥和藥品的需求。

此外，技術進步、臨床測試全球化以及 CRO 進行臨床測試的需求不斷增加等因素預計將加速該行業的擴張。然而，由於 COVID-19 大流行，主要製藥和生物分析公司遇到了挑戰，擾亂了臨床研究和治療。除了 COVID-19計劃的工作量（包括啟動臨床測試、臨床前測試、生物分析以及與監管機構的互動）之外，其他挑戰還包括現場工人的流失。非新冠病毒舉措被推遲，資源被用於支持新冠病毒檢測的生物分析、臨床前和臨床檢測，導致等待時間長達 4-6 個月。我們還必須弄清楚哪些檢測與新冠病毒相關，哪些不相關。

聚合物生物分析測試服務市場報告亮點

  • 2024年，臨床市場佔有率佔有率，達到66.6%。開發中國家慢性病盛行率的增加和臨床檢測需求的增加預計將成為推動該領域成長的因素。
  • 全球市場分為藥物動力學、抗藥抗體（ADA）等。 2024 年，ADA 細分市場在全球市場中佔據最大的收益佔有率。
  • 2024 年，生物有效性領域佔據最大收益佔有率。該細分市場的成長是由於學名藥製造中對這些服務的高需求。
  • 2024年全球市場中，腫瘤學佔大部分收益佔有率。預計該細分市場在預測期內的複合年成長率也將是最快的。
  • 2024年，市場區隔將主導全球市場。預計該細分市場將以最快的複合年成長率成長，並在預測期內保持其市場主導地位。
  • 北美聚合物生物分析測試服務市場主導全球市場，2024年收益佔有率超過48.94%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章高分子生物分析測試服務市場的變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 研發投資金籌措視角
  • 臨床試驗量分析（2023）
  • 定價模式分析
  • 技術景觀
  • 聚合物生物分析測試服務市場分析工具
    • 波特五力分析
    • PESTEL分析

第4章 聚合物生物分析測試服務市場：分階段估計與趨勢分析

  • 聚合物生物分析測試服務市場，依階段：細分儀表板
  • 全球聚合物生物分析測試服務市場分階段：波動分析
  • 愛別，2018-2030（百萬美元）
  • 臨床前
    • 有抗體
    • 無抗體（基於 ELISA 的檢測）
  • 臨床

第5章聚合物生物分析測試服務市場：按類型估計和趨勢分析

  • 聚合物生物分析測試服務市場，按類型：細分儀表板
  • 全球聚合物生物分析測試服務市場（按類型）：變異分析
  • 按類型分類，2018-2030（百萬美元）
  • 藥物動力學
    • 2018-2030年藥物動力學市場估計與預測
  • ADA
    • 2018-2030 年 ADA 市場估算與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第6章 聚合物生物分析測試服務市場：依測試類型估算與趨勢分析

  • 聚合物生物分析測試服務市場，按測試類型：細分儀表板
  • 按測試類型分類的全球聚合物生物分析測試服務市場：變異分析
  • 按測試類型，2018-2030（百萬美元）
  • ADME
  • PD
  • 生物有效性
  • 生物等效性
  • 其他

第7章 高分子生物分析檢測服務市場：依治療領域估算及趨勢分析

  • 聚合物生物分析測試服務市場，按治療領域：細分儀表板
  • 按治療領域分類的全球聚合物生物分析測試服務市場：波動分析
  • 按治療領域，2018-2030 年（百萬美元）
  • 腫瘤學
    • 2018-2030 年腫瘤學市場估計與預測
  • 感染疾病
    • 2018-2030年感染疾病市場估計與預測
  • 心臟病
    • 2018-2030年心臟病市場估計與預測
  • 神經病學
    • 2018-2030 年神經病學市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第8章聚合物生物分析測試服務市場：按最終用途分類的估算和趨勢分析

  • 聚合物生物分析測試服務市場，依最終用途：細分儀表板
  • 全球聚合物生物分析測試服務市場（按最終用途）：變化分析
  • 按最終用途分類，2018-2030 年（百萬美元）
  • 小型企業
    • 2018-2030 年小型企業市場估計與預測
    • 合約研究官（CRO）和首席行銷長（CMO）
    • 贊助機構
    • 其他
  • 主要企業
    • 2018-2030年大公司市場估計與預測
    • 合約研究官（CRO）和首席行銷長（CMO）
    • 贊助機構
    • 其他

第9章聚合物生物分析測試服務市場：按地區估算及趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 泰國
    • 韓國
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭格局

  • 市場分類
  • Market Leaders
  • Emerging Players
  • 2024 年市場分析
  • 公司簡介
    • Laboratory Corporation of America Holdings
    • IQVIA
    • Syneous Health
    • SGS, SA
    • WuXi AppTec
    • Intertek Plc
    • Pace Analytical Services LLC
    • ICON PLC
    • Charles River Laboratories
    • ThermoFisher Scientific
Product Code: GVR-4-68038-979-1

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.70 billion by 2030, registering a CAGR of 9.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • The clinical phase segment dominated the market in 2024 with the largest revenue share of 66.6%. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth.
  • The global market is segmented into pharmacokinetics, Antidrug Antibodies (ADA), and others. The ADA segment accounted for the largest revenue share of the global market in 2024.
  • The bioavailability segment held the largest revenue share in 2024. The segment growth can be attributed to the high demand for these services in generic drug manufacturing.
  • Oncology accounted for a majority of revenue share in the global market in 2024. The segment is also anticipated to register the fastest CAGR during the forecast period.
  • The SMEs segment dominated the global market in 2024. The segment is also anticipated to grow at the fastest CAGR over the forecast timeline, retaining its market dominance.
  • North America large molecule bioanalytical testing services market dominated globally in 2024 with a revenue share of more than 48.94%.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Area
    • 1.1.5. End Use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological advancements in analytical testing
      • 3.2.1.2. Regulatory control and increasing awareness regarding bioanalytical testing
      • 3.2.1.3. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.2.1.4. Rising demand for outsourcing of analytical testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance issues while outsourcing
      • 3.2.2.2. Data security concerns
  • 3.3. R&D Investments & Funding Perspective
  • 3.4. Clinical Trials Volume Analysis, (2023)
  • 3.5. Pricing Model Analysis
  • 3.6. Technology Landscape
  • 3.7. Large Molecule Bioanalytical Testing Services Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

  • 4.1. Large Molecule Bioanalytical Testing Services Market, By Phase: Segment Dashboard
  • 4.2. Global Large Molecule Bioanalytical Testing Services Market by Phase: Movement Analysis
  • 4.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million) for the following
  • 4.4. Preclinical
    • 4.4.1. Preclinical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. With Antibody
      • 4.4.2.1. With Antibody market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Without Antibody (ELISA Based Assay)
      • 4.4.3.1. Without Antibody (ELISA Based Assay) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Clinical
    • 4.5.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

  • 5.1. Large Molecule Bioanalytical Testing Services Market, By Type: Segment Dashboard
  • 5.2. Global Large Molecule Bioanalytical Testing Services Market by Type: Movement Analysis
  • 5.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030 (USD Million) for the following
  • 5.4. Pharmacokinetics
    • 5.4.1. Pharmacokinetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. ADA
    • 5.5.1. ADA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Large Molecule Bioanalytical Testing Services Market, By Test: Segment Dashboard
  • 6.2. Global Large Molecule Bioanalytical Testing Services Market by Test Type: Movement Analysis
  • 6.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million) for the following
  • 6.4. ADME
    • 6.4.1. ADME market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PD
    • 6.5.1. PD market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Bioavailability
    • 6.6.1. Bioavailability market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Bioequivalence
    • 6.7.1. Bioequivalence market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Other Tests
    • 6.8.1. Other tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Area Estimates & Trend Analysis

  • 7.1. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area: Segment Dashboard
  • 7.2. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Area: Movement Analysis
  • 7.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million) for the following
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cardiology
    • 7.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End Use Estimates & Trend Analysis

  • 8.1. Large Molecule Bioanalytical Testing Services Market, By End Use: Segment Dashboard
  • 8.2. Global Large Molecule Bioanalytical Testing Services Market by End Use: Movement Analysis
  • 8.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million) for the following
  • 8.4. SMEs
    • 8.4.1. SMEs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. CROs & CMOs
      • 8.4.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Sponsor Organizations
      • 8.4.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Large Firms
    • 8.5.1. Large Firms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. CROs & CMOs
      • 8.5.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. Sponsor Organizations
      • 8.5.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Others
      • 8.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 9.1. Regional market share analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Thailand large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. South Korea large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.7. Australia
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Australia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. Colombia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Colombia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Categorization
  • 10.2. Market Leaders
  • 10.3. Emerging Players
  • 10.4. Market Position Analysis, 2024
  • 10.5. Company Profiles
    • 10.5.1. Laboratory Corporation of America Holdings
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Service benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. IQVIA
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Service benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Syneous Health
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Service benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. SGS, SA
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Service benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. WuXi AppTec
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Service benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Intertek Plc
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Service benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Pace Analytical Services LLC
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Service benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. ICON PLC
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Service benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. Charles River Laboratories
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Service benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. ThermoFisher Scientific
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Service benchmarking
      • 10.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 7 Global Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Large Molecule Bioanalytical Testing Services, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 12 North America Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 North America Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 14 North America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 17 U.S. Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 18 U.S. Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 22 Canada Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Canada Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 24 Canada Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 26 Mexico Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 27 Mexico Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 28 Mexico Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Mexico Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 33 Europe Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 34 Europe Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 35 Europe Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 37 Germany Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 38 Germany Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 39 Germany Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 40 Germany Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 41 UK Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 42 UK Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 43 UK Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 UK Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 45 UK Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 46 France Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 47 France Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 48 France Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 49 France Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 France Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 52 Italy Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 54 Italy Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Italy Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 57 Spain Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 58 Spain Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 59 Spain Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Spain Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 62 Denmark Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 64 Denmark Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 67 Sweden Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 69 Sweden Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 Sweden Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 72 Norway Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 73 Norway Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 74 Norway Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 75 Norway Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 82 China Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 83 China Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 84 China Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 85 China Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 China Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Japan Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 88 Japan Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 89 Japan Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 90 Japan Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 Japan Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 92 India Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 93 India Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 94 India Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 95 India Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 96 India Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 97 South Korea Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 98 South Korea Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 99 South Korea Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 100 South Korea Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 South Korea Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Australia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 103 Australia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 104 Australia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 105 Australia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Australia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 108 Thailand Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 109 Thailand Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 110 Thailand Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 Thailand Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 114 Latin America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 116 Latin America Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 Latin America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 119 Brazil Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 120 Brazil Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 121 Brazil Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Brazil Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 124 Argentina Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 126 Argentina Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 135 South Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 137 South Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 138 South Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 145 UAE Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 147 UAE Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 UAE Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Large Molecule Bioanalytical Testing Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Large Molecule Bioanalytical Testing Services, for Preclinical, 2018 - 2030 (USD Million)
  • Fig. 13 Global Large Molecule Bioanalytical Testing Services, for With Antibody, 2018 - 2030 (USD Million)
  • Fig. 14 Global Large Molecule Bioanalytical Testing Services, for Without Antibody (ELISA Based Assay), 2018 - 2030 (USD Million)
  • Fig. 15 Global Large Molecule Bioanalytical Testing Services, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Large Molecule Bioanalytical Testing Services, for Pharmacokinetics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Large Molecule Bioanalytical Testing Services, for ADA, 2018 - 2030 (USD Million)
  • Fig. 18 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Large Molecule Bioanalytical Testing Services, for ADME, 2018 - 2030 (USD Million)
  • Fig. 20 Global Large Molecule Bioanalytical Testing Services, for PD, 2018 - 2030 (USD Million)
  • Fig. 21 Global Large Molecule Bioanalytical Testing Services, for Bioavailability, 2018 - 2030 (USD Million)
  • Fig. 22 Global Large Molecule Bioanalytical Testing Services, for Bioequivalence , 2018 - 2030 (USD Million)
  • Fig. 23 Global Large Molecule Bioanalytical Testing Services, for Other Tests, 2018 - 2030 (USD Million)
  • Fig. 24 Global Large Molecule Bioanalytical Testing Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Large Molecule Bioanalytical Testing Services, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 26 Global Large Molecule Bioanalytical Testing Services, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 27 Global Large Molecule Bioanalytical Testing Services, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 28 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Large Molecule Bioanalytical Testing Services, for SMEs, 2018 - 2030 (USD Million)
  • Fig. 30 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 31 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 32 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Large Molecule Bioanalytical Testing Services, for Large Firms, 2018 - 2030 (USD Million)
  • Fig. 34 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 35 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 36 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2024 & 2030
  • Fig. 38 North America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 India Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 China Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Colombia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)